BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Western Australian Health Translation Network - ECPv6.3.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Western Australian Health Translation Network
X-ORIGINAL-URL:https://wahtn.org
X-WR-CALDESC:Events for Western Australian Health Translation Network
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Shanghai
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:CST
DTSTART:20260101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Asia/Shanghai:20261007T160000
DTEND;TZID=Asia/Shanghai:20261007T180000
DTSTAMP:20260822T032125
CREATED:20260731T034751Z
LAST-MODIFIED:20260820T062728Z
UID:10222-1791388800-1791396000@wahtn.org
SUMMARY:WAHTN CTEP-WA Clinical Trials Forum
DESCRIPTION:The WA Clinical Trials Forum is a new initiative of the WAHTN Clinical Trials Enabling Platform-WA (CTEP-WA) to help support a thriving clinical trials ecosystem in WA by bringing together clinicians and researchers to strengthen the design of clinical trials. \nWednesday 7 October 2026 4:00 PM – 6:00 PM \nRepurposing Probucol for Childhood Dementia: A Phase II Feasibility Study \nChildhood dementia encompasses a group of rare\, progressive neurodegenerative disorders that collectively affect more than 100 genetic conditions\, with no approved disease-modifying therapies for most children. We propose a 52-week\, investigator-initiated\, open-label Phase II feasibility study evaluating oral probucol in children with genetically confirmed Batten disease\, Niemann-Pick disease type C\, Sanfilippo syndrome (MPS III) or Leigh syndrome. The primary objectives are to establish the feasibility of recruitment and retention\, treatment adherence and the safety and tolerability of long-term probucol administration in this population\, while collecting preliminary clinical\, functional and biomarker data to inform future controlled studies. \nDoors will open with light refreshments provided at 4:15pm\, with the presentation and panel starting at 4:30\, ending with a networking session to 6pm. \nVenue: McCusker Auditorium\, at the Harry Perkins Institute of Medical Research\, 6 Verdun St Nedlands WA (QEII Campus) \nThe forum will open at 4:15\, with the presentation and panel starting at 4:30. The day will end with a networking session to 6pm. Light refreshments provided. \nOnline: An online livestream option is available for those who cannot attend in person. Select the ‘Online’ ticket type using the registration link above. \nYou can find out more about the event and register here: https://www.trybooking.com/DNAYR
URL:https://wahtn.org/event/wahtn-ctep-wa-clinical-trials-forum/
LOCATION:McCusker Auditorium\, Harry Perkins Institute of Medical Research\, North Building\, 6 Verdun Street\, Nedlands\, Western Australia\, 6009\, Australia
END:VEVENT
END:VCALENDAR